Recently, STAT4 indirectly modulated MHC‐I neoantigen presentation and CTL‐mediated anti‐tumor effect via KDM5D–AP1/2–MHC‐I pathway in colon cancer,41 however this mechanism is still unexplored in breast cancer (Figure S3). Here, KDM5D is linked to breast cancer.